The study cohort comprised 89 patients, with 33 diagnosed with ALK+ ALCL, 22 with ALK- ALCL, and 34 with PTCL, NOS (Table 1). Here, ALK is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.